Holly Watson

Doctor of Osteopathic Medicine,  Mayo Clinic - Rochester 

Location: India

Consulting Services

Hospital-Pharmacy-Insurance Journal Manuscript Data Science-Bioinformatics

Areas Of Interest

Ballotas Bodily Secretion Endothelium-Dependent Vasodilators Labial Frenum, Maxillary F-Box Domain Protein I Blood-Group Systems Pasteurella pneumotropica Cost, Direct Service Hydroxyacetate Ethers Dermatofibrosarcoma Protuberan, Giant Vertebro-Basilar Insufficiency Postviral Fatigue Syndromes Encephalopathies, Subcortical Arteriosclerotic Lipid Metabolism Disorder Complications, Infectious Pregnancy Embryonic Lethal, Abnormal Vision Like Proteins Branchiootorenal Syndrome 2 Microenvironment, Tumor Bioprostheses, Xenograft Dental Techniques, High Speed Mo1 Antigen Arteriosclerosis Bioluminescence Measurements Component 5a, Complement Cyclic AMP, 8-Br BG-00012

Professional Narrative

Dr. Holly Watson was born in DuBois, Pennsylvania and is a graduate of Villanova University. He obtained his medical degree at Thomas Jefferson University in Philadelphia. His residency was at Thomas Jefferson and its affiliated Wills Eye Hospital, and he completed his training with fellowships at the University of Connecticut incataract andcorneal surgery.

Dr. Watson has thirty years’ experience in ophthalmic surgery,withspecialinterestin cataract surgery,corneal transplantation,andlaserrefractiveprocedures.Heisa founding member of Precision LASIK Group, Chief of Ophthalmology at The Hospital ofCentral Connecticut,andco-medical director of the Connecticut eye bank.


Employment

Senior Director, Harvard Med 2011
Senior Director, Amgen 2011

Education

Bachelor of science in nursing, Yale School of Medicine 2011
Doctor of osteopathic medicine, Perelman School of Medicine 2003

Referees


Publications

Platt RJ, Chen S, Zhou Y, Yim MJ, Swiech L, Kempton HR, Dahlman JE, Parnas O, Eisenhaure TM, Jovanovic M, Graham DB, Jhunjhunwala S, Heidenreich M, Xavier RJ, Langer R, Anderson DG, Hacohen N, Regev A, Feng G, Sharp PA, Zhang F. CRISPR- Cas9 knockin mice for genome editing and cancer modeling. Cell. 2014 Oct 9;159(2):440-55. doi: 10.1016/j.cell.2014.09.014. Epub 2014 Sep 25. PMID: 25263330; PMCID: PMC4265475.

Reichmuth AM, Oberli MA, Jaklenec A, Langer R, Blankschtein D. mRNA vaccine delivery using lipid nanoparticles. Ther Deliv. 2016;7(5):319-34. doi: 10.4155/tde-2016-0006. Erratum in: Ther Deliv. 2016 Jun;7(6):411. PMID: 27075952; PMCID: PMC5439223.

Hou X, Zaks T, Langer R, Dong Y. Lipid nanoparticles for mRNA delivery. Nat Rev Mater. 2021;6(12):1078-1094. doi: 10.1038/s41578-021-00358-0. Epub 2021 Aug 10. PMID: 34394960; PMCID: PMC8353930.

Langer R, Vacanti J. Advances in tissue engineering. J Pediatr Surg. 2016 Jan;51(1):8-12. doi: 10.1016/j.jpedsurg.2015.10.022. Epub 2015 Nov 10. PMID: 26711689; PMCID: PMC4733916.


Grants,Awards and Certifications

Grants :

No Grants Mentioned !!

Awards & Prizes :


Languages

Language Proficiency :

Translation Services :